| Laboratory Corporation of America Holdings is a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. Co. reports its business in two segments, LabCorp Diagnostics (Dx) and Labcorp Drug Development (DD). Dx is an independent clinical laboratory business. Co. provides a menu of frequently requested primary testing and specialty testing through a network of primary and specialty laboratories across the U.S. DD provides end-to-end drug development, medical device and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. We show 53 historical shares outstanding datapoints in our LH shares outstanding history coverage, used to compute LH market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing LH market cap history over the course of time is important for investors
interested in comparing LH's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of LH versus a peer is one thing; comparing
LH market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like LH can fluctuate over the course of history.
With this page we aim to empower investors researching LH by allowing them to research the LH market cap history.